Role of HbA1c in the screening of diabetes mellitus in a Korean rural community

Diabetes and Metabolism Journal

Volumn 36, Issue 1, 2012, Pages 37-42

  Kim, Jae Hyun ^a   Kim, Gun Woo ^a   Lee, Mi Young ^a   Shin, Jang Yel ^a   Shin, Young Goo ^a   Koh, Sang Baek ^a   Chung, Choon Hee ^a  

^a Yonsei University Wonju College of Medicine   (South Korea)

Author keywords

Diabetes mellitus; Diagnosis; Glycosylated; Hemoglobin A; Screening

Indexed keywords

EID: 84864634155     PISSN: 22336079     EISSN: 22336087     Source Type: Journal    
DOI: 10.4093/dmj.2012.36.1.37     Document Type: Article

References (32)

1. King H, Aubert RE, Herman WH. Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care 1998;21:1414-31.
2. Saudek CD, Herman WH, Sacks DB, Bergenstal RM, Edelman D, Davidson MB. A new look at screening and diagnosing diabetes mellitus. J Clin Endocrinol Metab 2008;93:2447-53.
3. Sung KC, Rhee EJ. Glycated haemoglobin as a predictor for metabolic syndrome in non-diabetic Korean adults. Diabet Med 2007;24:848-54.
4. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1997;20:1183-97.
5. Bennett CM, Guo M, Dharmage SC. HbA(1c) as a screening tool for detection of type 2 diabetes: a systematic review. Diabet Med 2007;24:333-43.
6. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2010;33 Suppl 1:S62-9.
7. Korean Diabetes Association. Diagnosis and classification of diabetes. Clin Diabetes 2005;6:132-40.
8. Petersen PH, Jorgensen LG, Brandslund I, De Fine Olivarius N, Stahl M. Consequences of bias and imprecision in measurements of glucose and HbA1c for the diagnosis and prognosis of diabetes mellitus. Scand J Clin Lab Invest Suppl 2005;240:51-60.
9. Sacks DB, Bruns DE, Goldstein DE, Maclaren NK, McDonald JM, Parrott M. Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. Clin Chem 2002;48:436-72.
10. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977-86.
11. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998;352:837-53.
12. Buell C, Kermah D, Davidson MB. Utility of A1C for diabetes screening in the 1999 2004 NHANES population. Diabetes Care 2007;30:2233-5.
13. van Leiden HA, Dekker JM, Moll AC, Nijpels G, Heine RJ, Bouter LM, Stehouwer CD, Polak BC. Risk factors for incident retinopathy in a diabetic and nondiabetic population: the Hoorn study. Arch Ophthalmol 2003;121:245-51.
14. Tapp RJ, Tikellis G, Wong TY, Harper CA, Zimmet PZ, Shaw JE; Australian Diabetes Obesity and Lifestyle Study Group. Longitudinal association of glucose metabolism with retinopathy: results from the Australian Diabetes Obesity and Lifestyle (AusDiab) study. Diabetes Care 2008;31:1349-54.
15. Little RR, Rohlfing CL, Wiedmeyer HM, Myers GL, Sacks DB, Goldstein DE NGSP Steering Committee. The national glycohemoglobin standardization program: a five-year progress report. Clin Chem 2001;47:1985-92.
16. Nakagami T, Tominaga M, Nishimura R, Yoshiike N, Daimon M, Oizumi T, Tajima N. Is the measurement of glycated hemoglobin A1c alone an efficient screening test for undiagnosed diabetes? Japan National Diabetes Survey. Diabetes Res Clin Pract 2007;76:251-6.
17. Kim SY, Park JH, Kang SM, Jin HY, Baek HS, Park TS. Value of HbA1c for diabetic screening in subject with normal fasting glucose. Korean Diabetes J 2008;32 Suppl 2:S218.
18. Ku YH, Yoo SH, Jung HS, Lim S, Moon MK, Choi SH, Jang HC, Park KS, Kim SY, Lee HK, Cho YM. Diagnostic value of HbA1c different clinical setting with different prevelence of diabetes mellitus. Korean Diabetes J 2008;32 Suppl 8:S311.
19. Bae JC, Rhee EJ, Choi ES, Kim JH, Kim WJ, Yoo SH, Park SE, Park CY, Lee WY, Oh KW, Park SW, Kim SW. The cutoff value of HbA1c in predicting diabetes in Korean adults in a university hospital in Seoul. Korean Diabetes J 2009;33:503-10.
20. Jung JH, Kim ST, Cho YZ, Lee HN, Kim JY, Kim JH, Lim DM, Lee KW, Kim BJ, Park KY. Acceptability of HbA1c values as a diagnostic tool for diabetes mellitus in Korea. Korean J Med 2010;79:673-80.
21. Engelgau MM, Narayan KM, Herman WH. Screening for type 2 diabetes. Diabetes Care 2000;23:1563-80.
22. Rohlfing CL, Little RR, Wiedmeyer HM, England JD, Madsen R, Harris MI, Flegal KM, Eberhardt MS, Goldstein DE. Use of GHb (HbA1c) in screening for undiagnosed diabetes in the U.S. population. Diabetes Care 2000;23:187-91.
23. Eid WE, Pottala JV. Value of hemoglobin A1c in diagnosing diabetes mellitus within a chronic disease management system illustrated by the receiver operating characteristic curve. Endocr Pract 2010;16:14-20.
24. Larsen ML. The utility of glycated hemoglobin in identification of impaired glucose tolerance. Diabetes Res 1989;12:67-70.
25. Verrillo A, de Teresa A, Golia R, Nunziata V. The relationship between glycosylated haemoglobin levels and various degrees of glucose intolerance. Diabetologia 1983;24:391-3.
26. Weykamp CW, Penders TJ, Miedema K, Muskiet FA, van der Slik W. Standardization of glycohemoglobin results and reference values in whole blood studied in 103 laboratories using 20 methods. Clin Chem 1995;41:82-6.
27. Ministry of Health and Welfare; Korea Centers for Disease Control and Prevention: Korean National Health and Nutrition Examination Survey: the 4th report (2008). Available from: http://www.bokjiro.go.kr/data/statusView.do?board_sid=297&data_sid=209708&searchSort=REG_DESC&pageIndex=1&searchWrd=%EA%B5%AD%EB%AF%BC%EA%B1%B4%EA%B0%95%ED%86%B5%EA%B3%84&searchCont=&pageUnit=10 (updated 2009 Dec 12).
28. Centers for Disease Control and Prevention: National Health and Nutrition Examination Survey (NHANES) 2005-2006. Available from: http://www.cdc.gov/nchs/nhanes/nhanes2005-2006/nhanes05_06.htm (updated 2011 Apr 29).
29. Yoon KH, Ko SH, Cho JH, Lee JM, Ahn YB, Song KH, Yoo SJ, Kang MI, Cha BY, Lee KW, Son HY, Kang SK, Kim HS, Lee IK, Bonner-Weir S. Selective beta-cell loss and alpha-cell expansion in patients with type 2 diabetes mellitus in Korea. J Clin Endocrinol Metab 2003;88:2300-8.
30. McCarter RJ, Hempe JM, Chalew SA. Mean blood glucose and biological variation have greater influence on HbA1c levels than glucose instability: an analysis of data from the Diabetes Control and Complications Trial. Diabetes Care 2006;29:352-5.
31. Herman WH, Ma Y, Uwaifo G, Haffner S, Kahn SE, Horton ES, Lachin JM, Montez MG, Brenneman T, Barrett-Connor E; Diabetes Prevention Program Research Group. Differences in A1C by race and ethnicity among patients with impaired glucose tolerance in the Diabetes Prevention Program. Diabetes Care 2007;30:2453-7.
32. Selvin E, Zhu H, Brancati FL. Elevated A1C in adults without a history of diabetes in the U.S. Diabetes Care 2009;32:828-33